• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

SPDR S&P Pharmaceuticals ETF

+ Add to Watchlist

XPH:US

115.0900 USD 0.1100 0.10%

As of 17:15:05 ET on 11/28/2014.

Snapshot for SPDR S&P Pharmaceuticals ETF (XPH)

Open: 115.1900 High - Low: 116.3600 - 114.9600 Primary Exchange: NYSE Arca
Volume: 40,833 52-Week Range: 83.9623 - 116.3600 Beta vs SPSIPHTR: 1.0011

ETF Chart for XPH

No chart data available.
  • XPH:US 115.0900
  • 1D
  • 1M
  • 1Y
115.2000
Interactive XPH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for XPH

SPDR Pharmaceuticals ETF is an exchange-traded fund incorporated in the USA. The Fund's objective is to replicate as closely as possible the performance of the S&P Pharmaceuticals Select Industry Index, an equal-weighted index.

Inception Date: 2006-06-22 Telephone: 1-866-787-2257
Managers: JOHN A TUCKER / MICHAEL FEEHILY
Web Site: www.spdrs.com

Fundamentals for XPH

NAV (on 2014-11-26) 115.1964
Assets (M) (on 2014-11-26) 1,105.9010
Shares out (M) 9.60
Market Cap (M) 1,104.88
% Premium 0.00
Average 52-Week % Premium 0.0141
Fund Leveraged N

Dividends for XPH

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2014-09-19) 0.2387
Dividend Yield (ttm) 1.68%

Performance for XPH

1-Month +6.78% 1-Year +34.49%
3-Month +11.81% 3-Year +37.91%
Year To Date +31.60% 5-Year +26.95%
Expense Ratio 0.35

Top Fund Holdings for XPH

Filing Date: 11/26/2014
Name Position Value % of Total
Auxilium Pharmaceuticals Inc 1,469,396 50,370,895 4.560%
Avanir Pharmaceuticals Inc 3,314,749 49,754,382 4.504%
Impax Laboratories Inc 1,368,379 44,226,009 4.004%
Allergan Inc/United States 195,139 41,759,746 3.780%
Lannett Co Inc 834,783 41,330,106 3.741%
Mylan Inc/PA 701,884 41,144,440 3.725%
Zoetis Inc 912,993 40,783,397 3.692%
AbbVie Inc 570,671 39,205,098 3.549%
Bristol-Myers Squibb Co 657,231 38,684,617 3.502%
Actavis plc 140,957 38,124,640 3.451%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil